Showing results (481-490 of 569) with videos related to

Sort By:
Pageof 57
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patientsM T Huizing, A C Keung, H Rosing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1995
Prognostic relevance of P-glycoprotein expression in breast cancerS C Linn, G Giaccone, P J van Diest, et al.
Cancer Research|April 1, 1986
Phase I study of ethylenediamine platinum(II) malonate (NSC 146 068), a second generation platinum analogueB Winograd, J B Vermorken, W W ten Bokkel Huinink, et al.
Gene Therapy|September 1, 1999
Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAMH J Haisma, H M Pinedo, A Rijswijk, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 1994
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pumpG J Zaman, M J Flens, M R van Leusden, et al.
The Journal of Biological Chemistry|November 7, 1998
A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistanceG Jansen, R Mauritz, S Drori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Conditionally replicative adenovirus with tropism expanded towards integrins inhibits osteosarcoma tumor growth in vitro and in vivoAdhiambo M Witlox, Victor W Van Beusechem, Bonnie Molenaar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agentH R Hendriks, J Plowman, D P Berger, et al.
British Journal of Cancer|December 23, 1998
Characterization of human soft-tissue sarcoma xenografts for use in secondary drug screeningE Boven, H M Pinedo, A H van Hattum, et al.
Gene Therapy|October 7, 2003
Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumorsV W van Beusechem, D C J Mastenbroek, P B van den Doel, et al.
Pageof 57